A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes

Erstveröffentlichung

2004

Authors

Stadler, M

Germing, U

Kliche, KO

Josten, KM

Kuse, R

et al.

Wissenschaftlicher Artikel

Published in

Leukemia ; 18 (2004), 3. - S. 460-465. - ISSN 0887-6924

Link to publication

https://dx.doi.org/10.1038/sj.leu.2403239

Institutions

UKU. Klinik für Innere Medizin III

Subject headings

[Free subject headings]: myelodysplastic syndromes | immune modulation | antithymocyte globulin | antilymphocyte globulin | aplastic-anemia | bone-marrow | immunosuppressive therapy | classification | cyclosporine | prognosis | cells | atg
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record